Grifols SA - ADR ADR Class B (GRFS) is lower by Monday morning, with the stock losing -1.47% in pre-market trading to 6.04.
GRFS's short-term technical score of 10 indicates that the stock has traded less bullishly over the last month than 90% of stocks on the market. In the Drug Manufacturers - General industry, which ranks 123 out of 146 industries, GRFS ranks higher than 13% of stocks.
Grifols SA - ADR ADR Class B has fallen 27.63% over the past month, closing at $8.54 on February 19. During this period of time, the stock fell as low as $5.47 and as high as $9.37. GRFS has an average analyst recommendation of Sell. The company has an average price target of $11.75.
GRFS has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on GRFS!
Grifols SA - ADR ADR Class B has a Long-Term Technical rank of 5. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 95% of the market scoring higher. In the Drug Manufacturers - General industry which is number 112 by this metric, GRFS ranks better than 112% of stocks.
